Proteolytic processing of big endothelin-3 by the Kell blood group protein

Blood

Volumn 94, Issue 4, 1999, Pages 1440-1450

  Lee, Soohee ^a   Lin, Melissa ^a   Mele, Aldo ^a   Cao, Ying ^a   Farmar, James ^a   Russo, David ^a   Redman, Colvin ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 3;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BLOOD GROUP KELL SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SEQUENCE HOMOLOGY;

EID: 0033566651     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1440     Document Type: Article

References (39)

1. Lee S, Zambas ED, Marsh WL, Redman CM: Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 88:6353, 1991
2. Redman CM, Marsh WL: The Kell blood group system and the McLeod phenotype (review). Semin Hematol 30:209, 1993
3. Lee S: Molecular basis of Kell blood group phenotypes. Vox Sang 73:1, 1997
4. Turner AJ, Murphy LJ: Molecular pharmacology of endothelin converting enzymes (review). Biochem Pharmacol 51:91, 1996
5. Turner AJ, Tanzawa K: Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11:355, 1997
6. Emoto N, Yanagisawa M: Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262, 1995
7. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M: ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473, 1994
8. Shipp MA, Richardson NE, Sayre PH, Brown NR, Masteller EL, Clayton LK, Ritz J, Reinherz EL: Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci USA 85:4819, 1988
9. Shipp MA, Look AT: Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key (review). Blood 82:1052, 1993
10. Turner AJ, Murphy LJ, Medeiros MS, Barnes K: Endopeptidase-24.11 (Neprilysin) and Relatives. Twenty years on, in Suzuki K, Bond J (eds): Intracellular Protein Catabolism. New York, NY, Plenum, 1996, p 141
11. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759, 1993
12. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda, Kuwaki T, Cao WH, Kamada N: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703, 1994
13. Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M: Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277, 1994
14. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A: A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257, 1994
15. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K: Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85:6964, 1988
16. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411, 1988
17. Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Dumas ME, JB, Stumpf JG, Loffler BM: Human endothelin-converting enzyme (ECE-1): Three isoforms with distinct subcellular localizations. Biochem J 328:871, 1997
18. Shimada K, Takahashi M, Ikeda M, Tanzawa K: Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett 371:140, 1995
19. Valdenaire O, Rohrbacher E, Mattei MG: Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 270:29794, 1995
20. Hasegawa H, Hiki K, Sawamura, Aoyama T, Okamoto Y, Miwa S, Shimohama S, Kimura J, Masaki T: Purification of a novel endothelin-converting enzyme specific for big endothelin-3. FEBS Lett 428:304, 1998
21. Hoang VM, Turner AJ: Novel activity of endothelin converting enzyme: Hydrolysis of bradykinin. Biochem J 327:23, 1997
22. The HYP Consortium: A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130, 1995
23. Rowe PS, Oudet CL, Francis F, Sinding C, Pannetier S, Econs MJ, Strom TM, Meitinger T, Garabedian M, David A, Macher MA, Questiaux E, Popowska E, Pronicka E, Read AP, Mokrzycki A, Glorieux FH, Drezner, MK, Hanauer A, Lehrach H, Goulding JN, O'Riordan JL: Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet 6:539, 1997
24. Lipman ML, Panda D, Bennett HPJ, Henderson JE, Shane E, Shen YN, Goltzman D, Karaplis AC: Cloning of human PEX cDNA-Expression, subcellular localization, and endopeptidase activity. J Biol Chem 273:13729, 1998
25. Lemay G, Waksman G, Roques BP, Crine P, Boileau G: Fusion of a cleavable signal peptide to the ectodomain of neutral endopeptidase (EC 3.4.24.11) results in the secretion of an active enzyme in COS-1 cells. J Biol Chem 264:15620, 1989
26. Korth P, Egidy G, Parnot C, LeMoullec J-M, Corvol P, Pinet F: Constrution, expression and characterization of a soluble form of human endothelin-converting-enzyme-1. FEBS Lett 417:365, 1997
27. Ahn K, Herman SB, Fahnoe DC: Soluble human endothelin-converting enzyme-1: Expression, purification, and demonstration of pronounced pH sensitivity. Arch Biochem Biophys 359:258, 1998
28. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A: Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology (review). Pharmacol Rev 45:87, 1993
29. Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O: Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 228:931, 1995
30. Russo D, Redman C, Lee S: Association of XK and Kell blood group proteins. J Biol Chem 273:13950, 1998
31. 412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem J 315:863, 1996
32. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77:869, 1994
33. Lee S, Wu X, Reid M, Redman C: Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 35:822, 1995
34. Redman CM, Avellino G, Pfeffer SR, Mukherjee TK, Nichols M, Rubinstein P, Marsh WL: Kell blood group antigens are part of a 93,000-dalton red cell membrane protein. J Biol Chem 261:9521, 1986
35. McKerrow JH: Human fibroblast collagenase contains an amino acid sequence homologous to the zinc-binding site of Serratia protease. J Biol Chem 262:5943, 1987
36. Jongeneel CV, Bouvier J, Bairoch A: A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett 242:211, 1989
37. Devault A, Nault C, Zollinger M, Fournie-Zaluski M-C, Roques BP, Crine P, Boileau G: Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. J Biol Chem 263:4033, 1988
38. Lee S, Zambas ED, Marsh WL, Redman CM: The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 81:2804, 1993
39. Lahav R, Dupin E, Lecoin L, Glavieux C, Champeval D, Ziller C, Le Douarin NM: Endothelin 3 selectively promotes survival and proliferation of neural crest-derived glial and melanocytic precursors in vitro. Proc Natl Acad Sci USA 95:14214, 1998